Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Fireman B.V. (NQ: IFRX )

2.840 USD -0.020 (-0.70%)
Streaming Delayed Price Updated: 12:36 PM EDT, Oct 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 762,193
Open 2.910
Bid (Size) 2.830 (2)
Ask (Size) 2.850 (2)
Prev. Close 2.860
Today's Range 2.780 - 3.000
52wk Range 2.230 - 6.880
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
InflaRx to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
From GlobeNewswire News Releases
InflaRx to Proceed with Pivotal Development for Vilobelimab in Hidradenitis Suppurativa with New Primary Endpoint
From GlobeNewswire News Releases

Performance

YTD
-44.75%
-44.75%
1 Month
+4.03%
+4.03%
3 Month
+14.52%
+14.52%
6 Month
-27.92%
-27.92%
1 Year
-34.26%
-34.26%

More News

Read More
InflaRx Announces Positive Data from Second Interim Analysis of Ongoing Phase IIa Open Label Study with Vilobelimab in Pyoderma Gangraenosum
From GlobeNewswire News Releases
InflaRx to Present at the BTIG Virtual Biotechnology Conference
From GlobeNewswire News Releases
InflaRx Secures €44M Grant From German Govt To Advance Its COVID-19 Trial
Tags Phase 3 Long Ideas Movers
From Benzinga
InflaRx Reports Second Quarter 2021 Financial & Operating Results
From GlobeNewswire News Releases
Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher
Tags EVER Mid/Afternoon Market Update Benzinga
From Benzinga
Mid-Day Market Update: Silver Surges 3%; Galera Therapeutics Shares Plunge
Tags Earnings Markets Small Cap
From Benzinga
Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance
Tags Penny Stocks HRMY IFRX
From Benzinga
InflaRx's Vilobelimab Shows Encouraging Signs Of Drug Activity In Mid-Stage Study With Dermatological Ulcer Patients
Tags Market News Health Care Ulcers
From Benzinga
52 Biggest Movers From Yesterday
Tags SLHG IT Consulting & Other Services DLO
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]